User:GarryGaller2/sandbox: Difference between revisions
GarryGaller2 (talk | contribs) John Stuelpnagel |
(No difference)
|
Latest revision as of 20:51, 30 September 2021
John Stuelpnagel | |
|---|---|
| Born | John R. Stuelpnagel |
| Nationality | American |
| Alma mater | University of California, Davis (B.S) (D.V.M.) UCLA Anderson School of Management (MBA) |
| Occupation(s) | Founder and CEO of Illumina, Inc. (1998 - 2009) Chairman and Co-founder of Fabric Genomics (2009 - Present) Chairman of 10x Genomics (2013 - Present) |
| Website | fabricgenomics |
John R. Stuelpnagel is an American venture capitalist, inventor, medical researcher and publicist, specializing in biotechnology.[1][2][3] He is mostly known for business and research contributions to DNA sequencing technology through co-founding Illumina, Inc.,[4] [5] a company that helped to reduce the cost of sequencing a human genome.[6][7][8] Stuelpnagel has also co-founded and ran multiple early-stage growth companies related to biotechnologies or genomics.[9][10] Stuelpnagel holds 35 issued U.S. patents.[6][11]
Background
[edit]Stuelpnagel finished his graduate studies at the University of California, Davis, where he received his B.S in biochemistry in 1979. Continuing his studies at the University of California, Davis, Stuelpnagel attained his D.V.M. within the field of Veterinary Medicine. In 1995, he entered the UCLA Anderson School of Management, where he earned a Master of Business Administration in 1997.[6]Stuelpnagel's research interests have been in the area of biotechnology and biochemistry with the main focus being on genetic sequencing and its applications in various fields of science. His work has been published in medical and biochemistry related journals. He is also co-inventor on 35 granted and 76 pending patents assigned by the United States Patent and Trademark Office (USPTO).[6][11]
Entrepreneurial activity
[edit]John Stuelpnagel co-founded and served as Chairman or CEO on a number of organization boards, including Illumina, Inc.,[12][13] 10x Genomics,[14] Fabric Genomics,[15] Element Biosciences,[16]
- ^ "The future of next-gen sequencing (and why an Illumina cofounder's never had his genome mapped)". MedCityNews.
{{cite web}}: no-break space character in|title=at position 4 (help) - ^ "Eight Lessons from John Stuelpnagel (Illumina)". Medium.
- ^ "Illumina's original people are coming soon, and the mysterious Chu CHUANG, who is at the helm of the Chinese executives, has attracted $400 million in 4 years to build a cheaper DNA sequencer". MinNews.
{{cite web}}: no-break space character in|title=at position 11 (help) - ^ "Illumina- The Origin story". www.linkedin.com.
- ^ "Illumina: Cheap With Further Upside From Grail". Seeking Alpha.
- ^ a b c d "2017 Alumni Achievement Award Recipients". UC Davis Veterinary Medicine.
{{cite web}}: no-break space character in|title=at position 5 (help) - ^ "Illumina-Maintaining Growth Momentum in a Plateauing Genome Sequencing Market". IBS Center for Management Research: 18. 2017.
- ^ "Illumina's CEO on the Promise of the $1,000 Genome -- And the Work That Remains". Recode. March 25, 2014.
{{cite news}}: Check date values in:|date=(help); no-break space character in|date=at position 6 (help) - ^ "John R. Stuelpnagel, Chairman, 10X Genomics, Inc". Wall Street Journal Markets.
{{cite web}}: no-break space character in|title=at position 5 (help) - ^ "John Stuelpnagel". MarketScreener.
{{cite web}}: no-break space character in|title=at position 5 (help) - ^ a b "Patents by Inventor John R. Stuelpnagel". Justia Patents.
- ^ "10 Biotechnology Companies That Rule in the United States". TechFlock.
- ^ "Illumina, Secret Giant Of DNA Sequencing, Is Bringing Its Tech To The Masses". Fast Company.
- ^ "Stealthy 10X Genomics Raises $55.5M To Beef Up DNA Sequencing". Forbes.
- ^ "Gene sequencing software company helps doctors personalize medicine". San Francisco Business Times.
- ^ "Promises of a next-gen sequencing approach earn Element Biosciences a hefty Series C. Is an IPO next?". Endpoint News.